Please see full Prescribing Information for EPCLUSA, including BOXED WARNING, at https://bit.ly/3mw8Klx and at hcp.EPCLUSA.com.
To report SUSPECTED ADVERSE REACTIONS, contact Gilead Sciences, Inc. at 1-800-GILEAD-5 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
EPCLUSA, the EPCLUSA Logo, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc., or its related companies.
©2024 Gilead Sciences, Inc.
All rights reserved. US-EPCP-0484 07/24
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://hcp.EPCLUSA.com/
- Keywords
- Philadelphia.
Epclusa® (Sofosbuvir 400 Mg/velpatasvir 100 Mg) Hcp Questions
Epclusa® (Sofosbuvir 400 Mg/Velpatasvir 100 Mg) Hcp's website is https://hcp.EPCLUSA.com/
Epclusa® (Sofosbuvir 400 Mg/Velpatasvir 100 Mg) Hcp's LinkedIn profile is https://www.linkedin.com/company/epclusahcp
Epclusa® (Sofosbuvir 400 Mg/Velpatasvir 100 Mg) Hcp's industry is
Pharmaceutical Manufacturing
Epclusa® (Sofosbuvir 400 Mg/Velpatasvir 100 Mg) Hcp's top competitors are
Moderna,
Camber Spine,
Bristol Myers Squibb,
Regeneron,
Sanofi,
Madrigal Pharmaceuticals,
Abbott,
Nxt Humans,
Acadia Pharmaceuticals Inc.,
Enhertu® (Fam-Trastuzumab Deruxtecan-Nxki) Hcp.
Epclusa® (Sofosbuvir 400 Mg/Velpatasvir 100 Mg) Hcp's categories are Pharmaceutical Manufacturing
